Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Clinical Outcome
9 results:

  • 1. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.
    Siriwardana PN; Luong TV; Watkins J; Turley H; Ghazaley M; Gatter K; Harris AL; Hochhauser D; Davidson BR
    Medicine (Baltimore); 2016 Feb; 95(8):e2924. PubMed ID: 26937938
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HIF-1α in colorectal carcinoma: review of the literature.
    Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
    J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
    Schweiger T; Kollmann D; Nikolowsky C; Traxler D; Guenova E; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):92-9. PubMed ID: 24321995
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.
    Pez F; Dayan F; Durivault J; Kaniewski B; Aimond G; Le Provost GS; Deux B; Clézardin P; Sommer P; Pouysségur J; Reynaud C
    Cancer Res; 2011 Mar; 71(5):1647-57. PubMed ID: 21239473
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Koike Y; Fujikawa H; Inoue Y; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):323-32. PubMed ID: 20970309
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.
    Mackay H; Hedley D; Major P; Townsley C; Mackenzie M; Vincent M; Degendorfer P; Tsao MS; Nicklee T; Birle D; Wright J; Siu L; Moore M; Oza A
    Clin Cancer Res; 2005 Aug; 11(15):5526-33. PubMed ID: 16061869
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and hif-1alpha induction pathway.
    Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
    Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.